Schematic view of the research
Researchers identified a single amino acid change in the tumor suppressor protein in PTEN that extends healthy periods while maintaining longevity
Living a long, healthy life is everyone’s wish, but it is not an easy one to achieve. Many aging studies are developing strategies to increase health spans, the period of life spent with good health, without chronic diseases and disabilities. Researchers at KAIST presented new insights for improving the health span by just regulating the activity of a protein.
A research group under Professor Seung-Jae V. Lee from the Department of Biological Sciences identified a single amino acid change in the tumor suppressor protein phosphatase and tensin homolog (PTEN) that dramatically extends healthy periods while maintaining longevity. This study highlights the importance of the well-conserved tumor suppressor protein PTEN in health span regulation, which can be targeted to develop therapies for promoting healthy longevity in humans. The research was published in Nature Communications on September 24, 2021.
Insulin and insulin-like growth factor-1 (IGF-1) signaling (IIS) is one of the evolutionarily conserved aging-modulatory pathways present in life forms ranging from tiny roundworms to humans. The proper reduction of IIS leads to longevity in animals but often causes defects in multiple health parameters including impaired motility, reproduction, and growth.
The research team found that a specific amino acid change in the PTEN protein improves health status while retaining the longevity conferred by reduced IIS. They used the roundworm C. elegans, an excellent model animal that has been widely used for aging research, mainly because of its very short normal lifespan of about two to three weeks. The PTEN protein is a phosphatase that removes phosphate from lipids as well as proteins. Interestingly, the newly identified amino acid change delicately recalibrated the IIS by partially maintaining protein phosphatase activity while reducing lipid phosphatase activity.
As a result, the amino acid change in the PTEN protein maintained the activity of the longevity-promoting transcription factor Forkhead Box O (FOXO) protein while restricting the detrimental upregulation of another transcription factor, NRF2, leading to long and healthy life in animals with reduced IIS.
Professor Lee said, “Our study raises the exciting possibility of simultaneously promoting longevity and health in humans by slightly tweaking the activity of one protein, PTEN.”
Original Article: A Genetic Change for Achieving a Long and Healthy Life?
More from: Korea Advanced Institute of Science and Technology
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Health span
- Healthy lifestyle may offset effects of life-shortening genes by more than 60%
Researchers say healthy lifestyle habits such as diet, exercise, not smoking, and limiting alcohol consumption can offset the effects of life-shortening genes and lower the risk of premature death ...
- Kids and their battles with kidney stones
When you think of kidney stones, you may think of middle-aged men. It's less common in children, but even that's changing. And for children, it can be a life-long battle.
- Living to 100: What Residents of the World’s ‘Blue Zones’ Do Differently
The lessons of the world's "blue zones," where people routinely live to 100, are that nine simple practices can help you live significantly longer.
- Identifying proteins causally related to COVID-19, healthspan and lifespan
A new research paper titled "Using genetics and proteomics data to identify proteins causally related to COVID-19, healthspan and lifespan: a Mendelian randomization study" has been published in Aging ...
- Think health-span, not lifespan
By Christie Pool Staff Writer [email protected] My mother’s family is very long-lived. She had one sister who passed away one week before her 96th birthday, another at age 93, and another ...
Go deeper with Google Headlines on:
Health span
[google_news title=”” keyword=”health span” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
PTEN protein
- Q1 2024 results
As announced at the Annual General Meeting on 11 April 2024, the total dividend for FY 2024 will increase by $0.20 per share to $3.10 per share "AstraZeneca had a very strong start in 2024 with ...
Go deeper with Google Headlines on:
PTEN protein
[google_news title=”” keyword=”PTEN protein” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]